News
07-15-2026, 12:50 PM
Modern anticancer medications that combine tumor-fighting drugs with proteins that specifically target cancer cells are a relatively new class of drug, often given to patients for whom standard chemotherapy has not worked.
More... (https://www.news-medical.net/news/20260715/Self-assembling-antibody-drugs-successfully-target-multiple-cancer-receptors.aspx)
More... (https://www.news-medical.net/news/20260715/Self-assembling-antibody-drugs-successfully-target-multiple-cancer-receptors.aspx)